Liver cancer study seeks clues in genes
NCT ID NCT05197504
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study looked at tumor and blood samples from 166 people with advanced liver cancer to find genetic markers that might predict how well they respond to treatment. The goal was to better understand the disease and identify new targets for therapy. Participants had already received a combination of two drugs, atezolizumab and bevacizumab.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, 13496, South Korea
Conditions
Explore the condition pages connected to this study.